Dynavax Technologies Corporation logo
Dynavax Technologies Corporation DVAX
$ 15.38 0.0%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Dynavax Technologies Corporation Long Term Debt Current 2011-2026 | DVAX

Annual Long Term Debt Current Dynavax Technologies Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.18 M 4.5 M 3.63 M 2.58 M 3.25 M 3.04 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.5 M 2.58 M 3.53 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Aclaris Therapeutics Aclaris Therapeutics
ACRS
481 K $ 2.92 -3.16 % $ 226 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.17 3.0 % $ 7.63 B australiaAustralia
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
675 K $ 11.32 0.27 % $ 732 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.96 -1.51 % $ 500 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 213.22 -0.01 % $ 5 B danmarkDanmark
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 0.19 -3.85 % $ 413 M israelIsrael
BioVie BioVie
BIVI
74.5 K $ 1.13 -2.59 % $ 1.67 M usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
210 K $ 11.52 -2.87 % $ 758 M usaUSA
Certara Certara
CERT
5.31 M $ 8.75 -0.68 % $ 1.4 B usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
11 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
3.29 M - -7.31 % $ 87 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Cellectis S.A. Cellectis S.A.
CLLS
8.38 M $ 4.81 -0.62 % $ 116 M franceFrance
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
5.38 M - -15.15 % $ 60.3 M britainBritain
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
59 K $ 3.2 8.47 % $ 39.1 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
BioNTech SE BioNTech SE
BNTX
39.5 M $ 97.01 1.9 % $ 27.2 B germanyGermany
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
6.8 M $ 26.25 -1.98 % $ 1.27 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
17.6 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Anika Therapeutics Anika Therapeutics
ANIK
1.6 M $ 9.59 -0.21 % $ 141 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
829 K $ 36.9 6.04 % $ 3.81 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
CorMedix CorMedix
CRMD
151 K $ 12.07 3.77 % $ 614 M usaUSA
Axon Enterprise Axon Enterprise
AXON
9.45 M $ 571.12 0.56 % $ 43.3 B usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.45 M $ 26.95 -0.79 % $ 1.74 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.6 - $ 16.3 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
339 M $ 91.95 0.02 % $ 96.9 B britainBritain